This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Series

Aaron Sato, PhD
Chief Scientific Officer at LakePharma, Inc.


Prior to joining LakePharma, Dr. Sato oversaw all research functions as the Vice President of Research at Sutro Biopharma, Inc . He has also served as Sr. Director of Antibody Engineering at OncoMed Pharmaceuticals, where he was responsible for human antibody lead discovery and engineering. In addition, he served as project team leader on several key antibody projects through IND filing. Before OncoMed, Dr. Sato was Sr. Director of Lead Discovery at Dyax Corp. and was responsible for antibody, peptide, and small protein discovery using their proprietary phage display technology. He obtained his doctorate degree from MIT where he studied MHC class II structure-function relationships. He is an author of over 30 peer reviewed papers, 40 issued patents in the antibody space.